Heidi L. Wagner, Director at Wave Life Sciences, Inc. (WVE), sold 7,000 shares at $6.01 ($42K) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2018-02-08 | $413K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $154K | — | Filing → |
| ALXN | SELL | 2017-10-04 | $17K | — | Filing → |